Search Results - "Zenari, L"

What are the preferred strategies for control of glycaemic variability in patients with type 2 diabetes mellitus? by Zenari, L., Marangoni, A.

“…The aim of therapy in type 2 diabetes in terms of blood glucose control is to reduce to target levels HbA1c and to reduce glycaemic variability in order to…”
Get full text

Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients by Targher, G, Bertolini, L, Chonchol, M, Rodella, S, Zoppini, G, Lippi, G, Zenari, L, Bonora, E

“…Aims/hypothesis Non-alcoholic fatty liver disease (NAFLD) is associated with an increased prevalence of chronic kidney disease (CKD) and retinopathy in…”
Get full text

Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue by Targher, G., Bertolini, L., Scala, L., Zoppini, G., Zenari, L., Falezza, G.

“…Aims  To compare plasma biomarkers of inflammation and endothelial dysfunction in individuals with and without non‐alcoholic hepatic steatosis (HS), and to…”
Get full text

Evidence of left atrial remodeling and left ventricular diastolic dysfunction in type 2 diabetes mellitus with preserved systolic function by Zoppini, G, Bonapace, S, Bergamini, C, Rossi, A, Trombetta, M, Lanzoni, L, Bertolini, L, Zenari, L, Bonora, E, Targher, G

“…Abstract Background and aims Prognosis of type 2 diabetes is associated with the occurrence of cardiovascular diseases. Left atrial (LA) size is a predictor of…”
Get full text

The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study by Bonora, E., Targher, G., Formentini, G., Calcaterra, F., Lombardi, S., Marini, F., Zenari, L., Saggiani, F., Poli, M., Perbellini, S., Raffaelli, A., Gemma, L., Santi, L., Bonadonna, R. C., Muggeo, M.

“…Aims  To evaluate the cardiovascular risk associated with the presence of the Metabolic Syndrome in Type 2 diabetic subjects. Methods  Subjects with the…”
Get full text

Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease by Targher, G., Bertolini, L., Padovani, R., Poli, F., Scala, L., Tessari, R., Zenari, L., Falezza, G.

“…Aims  To estimate the prevalence of cardiovascular disease (CVD) in Type 2 diabetic patients with and without non‐alcoholic fatty liver disease (NAFLD), and to…”
Get full text

Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy by Targher, G., Bertolini, L., Zoppini, G., Zenari, L., Falezza, G.

“…Aims  To evaluate whether plasma biomarkers of inflammation and endothelial dysfunction differed in Type 1 diabetic patients as compared with those in…”
Get full text

Anti-oxidant status and lipid peroxidation in patients with essential hypertension by Russo, Carla, Olivieri, Oliviero, Girelli, Domenico, Faccini, Giovanni, Zenari, Maria L, Lombardi, Sara, Corrocher, Roberto

“…BACKGROUNDLipid peroxidation and derived oxidized products are being intensively investigated, because of their potential to cause injury and their…”
Get full text

Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients by Targher, G., Bertolini, L., Zenari, L., Lippi, G., Pichiri, I., Zoppini, G., Muggeo, M., Arcaro, G.

“…Aims  We investigated the association of diabetic retinopathy with the risk of incident cardiovascular disease (CVD) events in a large cohort of Type 2…”
Get full text

Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients by Targher, G, Bertolini, L, Padovani, R, Poli, F, Scala, L, Zenari, L, Zoppini, G, Falezza, G

“…Non-alcoholic fatty liver disease (NAFLD) is closely associated with several metabolic syndrome (MetS) features. We assessed whether NAFLD is significantly…”
Get full text

Relationship of non-alcoholic hepatic steatosis to cortisol secretion in diet-controlled Type 2 diabetic patients by Targher, G., Bertolini, L., Zoppini, G., Zenari, L., Falezza, G.

“…Aims  To examine the association of non‐alcoholic hepatic steatosis (HS) with the activity of the hypothalamo‐pituitary‐adrenal (HPA) axis in Type 2 diabetic…”
Get full text

The International Diabetes Federation definition of the metabolic syndrome independently predicts future cardiovascular events in Type 2 diabetic patients. The Valpolicella Heart Diabetes Study by Targher, G., Bertolini, L., Tessari, R., Zenari, L., Arcaro, G.

Get full text

Measurement of microvolt T-wave alternans, a new arrhythmic risk stratification test, in Type 2 diabetic patients without clinical cardiovascular disease by Molon, G., Targher, G., Costa, A., Bertolini, L., Barbieri, E., Zenari, L.

“…Aims  Patients with a positive microvolt T‐wave alternans (TWA) are at increased risk of ventricular arrhythmias and sudden cardiac death. Although Type 2…”
Get full text

P5.27: Pulse Pressure is A Strong and Independent Predictor of Incident Atrial Fibrillation in Type 2 Diabetic Patients by Valbusa, F., Bonapace, S., Targher, G., Zenari, L., Arcaro, G.

“…Introduction Atrial fibrillation (AF) is the most common cause of chronic arrhythmia in adults and is associated with an increased risk of mortality and…”
Get full text

Pulse pressure is a strong and independent predictor of incident atrial fibrillation in type 2 diabetic patients by Valbusa, F, Bonapace, S, Targher, G, Zenari, L, Arcaro, G

Get full text

Predictors of insulin sensitivity in Type 2 diabetes mellitus by Bonora, E., Targher, G., Alberiche, M., Formentini, G., Calcaterra, F., Lombardi, S., Marini, F., Poli, M., Zenari, L., Raffaelli, A., Perbellini, S., Zenere, M. B., Saggiani, F., Bonadonna, R. C., Muggeo, M.

“…Aims To identify the independent predictors of insulin sensitivity in Type 2 diabetes, and to establish whether isolated Type 2 diabetes (i.e. diabetes without…”
Get full text

Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetes by Targher, G, Bertolini, L, Zenari, L, Cacciatori, V, Muggeo, M, Faccini, G, Zoppini, G

“…Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetes. G Targher , L Bertolini , L Zenari , V Cacciatori , M Muggeo , G…”
Get full text

Plasma total homocysteine levels are associated with von Willebrand factor, soluble intercellular adhesion molecule-1, and soluble tumor necrosis factor-alpha receptors in young type 1 diabetic patients without clinical evidence of macrovascular complications by Targher, G, Zenari, L, Bertolini, L, Falezza, G, Muggeo, M, Zoppini, G

Get full text

Increase in circulating products of lipid peroxidation in smokers with IDDM by ZOPPINI, G, TARGHER, G, MONAUNI, T, FACCINI, G, PASQUALINI, E, MARTINELLI, C, ZENARI, M. L, MUGGEO, M

“…Increase in circulating products of lipid peroxidation in smokers with IDDM. G Zoppini , G Targher , T Monauni , G Faccini , E Pasqualini , C Martinelli , M L…”
Get full text

Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients by TARGHER, Giovanni, BERTOLINI, Lorenzo, POLI, Felice, RODELLA, Stefano, SCALA, Luca, TESSARI, Roberto, ZENARI, Luciano, FALEZZA, Giancarlo

“…Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients Giovanni Targher 1 , Lorenzo Bertolini 1 , Felice Poli…”
Get full text